[(2S,3S,4R,5R)-2-[(2R,3R,4S,5R,6R)-4-[(2S,3R,4R,5R,6R)-5-acetyloxy-6-(acetyloxymethyl)-3-hydroxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-(acetyloxymethyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-5-[(E)-3-[4-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyphenyl]prop-2-enoyl]oxyoxan-2-yl]oxy-4-hydroxy-5-(hydroxymethyl)-2-[[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]oxymethyl]oxolan-3-yl] benzoate

Details

Top
Internal ID 02bc4ca8-55e3-47d0-b7cb-0506b49819a8
Taxonomy Organic oxygen compounds > Organooxygen compounds > Carbohydrates and carbohydrate conjugates > Oligosaccharides
IUPAC Name [(2S,3S,4R,5R)-2-[(2R,3R,4S,5R,6R)-4-[(2S,3R,4R,5R,6R)-5-acetyloxy-6-(acetyloxymethyl)-3-hydroxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-(acetyloxymethyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-5-[(E)-3-[4-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyphenyl]prop-2-enoyl]oxyoxan-2-yl]oxy-4-hydroxy-5-(hydroxymethyl)-2-[[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]oxymethyl]oxolan-3-yl] benzoate
SMILES (Canonical) CC1C(C(C(C(O1)OC2=CC=C(C=C2)C=CC(=O)OC3C(OC(C(C3OC4C(C(C(C(O4)COC(=O)C)OC(=O)C)OC5C(C(C(C(O5)CO)O)O)O)O)OC6C(C(C(C(O6)CO)O)O)O)OC7(C(C(C(O7)CO)O)OC(=O)C8=CC=CC=C8)COC(=O)C=CC9=CC=C(C=C9)O)COC(=O)C)O)O)O
SMILES (Isomeric) C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC2=CC=C(C=C2)/C=C/C(=O)O[C@@H]3[C@H](O[C@@H]([C@@H]([C@H]3O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)COC(=O)C)OC(=O)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)O[C@]7([C@H]([C@@H]([C@H](O7)CO)O)OC(=O)C8=CC=CC=C8)COC(=O)/C=C/C9=CC=C(C=C9)O)COC(=O)C)O)O)O
InChI InChI=1S/C67H84O38/c1-28-44(77)48(81)51(84)62(92-28)94-36-18-12-33(13-19-36)15-21-43(76)99-56-41(26-90-30(3)72)98-66(105-67(27-91-42(75)20-14-32-10-16-35(74)17-11-32)60(47(80)39(24-70)104-67)103-61(88)34-8-6-5-7-9-34)59(102-64-53(86)50(83)46(79)38(23-69)96-64)58(56)101-65-54(87)57(55(93-31(4)73)40(97-65)25-89-29(2)71)100-63-52(85)49(82)45(78)37(22-68)95-63/h5-21,28,37-41,44-60,62-66,68-70,74,77-87H,22-27H2,1-4H3/b20-14+,21-15+/t28-,37+,38+,39+,40+,41+,44-,45+,46+,47+,48+,49-,50-,51+,52+,53+,54+,55+,56+,57+,58-,59+,60-,62-,63-,64-,65-,66+,67-/m0/s1
InChI Key GAXCNXLJPQNOOP-AIIXUZBLSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C67H84O38
Molecular Weight 1497.40 g/mol
Exact Mass 1496.4640582 g/mol
Topological Polar Surface Area (TPSA) 563.00 Ų
XlogP -3.10
Atomic LogP (AlogP) -5.91
H-Bond Acceptor 38
H-Bond Donor 15
Rotatable Bonds 27

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of [(2S,3S,4R,5R)-2-[(2R,3R,4S,5R,6R)-4-[(2S,3R,4R,5R,6R)-5-acetyloxy-6-(acetyloxymethyl)-3-hydroxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-(acetyloxymethyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-5-[(E)-3-[4-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyphenyl]prop-2-enoyl]oxyoxan-2-yl]oxy-4-hydroxy-5-(hydroxymethyl)-2-[[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]oxymethyl]oxolan-3-yl] benzoate

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption - 0.7152 71.52%
Caco-2 - 0.8598 85.98%
Blood Brain Barrier - 0.5250 52.50%
Human oral bioavailability - 0.9143 91.43%
Subcellular localzation Mitochondria 0.7883 78.83%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.8224 82.24%
OATP1B3 inhibitior + 0.9248 92.48%
MATE1 inhibitior - 0.8800 88.00%
OCT2 inhibitior - 0.8750 87.50%
BSEP inhibitior + 0.8759 87.59%
P-glycoprotein inhibitior + 0.7434 74.34%
P-glycoprotein substrate + 0.6473 64.73%
CYP3A4 substrate + 0.7276 72.76%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8792 87.92%
CYP3A4 inhibition - 0.8472 84.72%
CYP2C9 inhibition - 0.8943 89.43%
CYP2C19 inhibition - 0.9008 90.08%
CYP2D6 inhibition - 0.9359 93.59%
CYP1A2 inhibition - 0.8990 89.90%
CYP2C8 inhibition + 0.8600 86.00%
CYP inhibitory promiscuity - 0.7794 77.94%
UGT catelyzed + 0.6000 60.00%
Carcinogenicity (binary) - 0.9600 96.00%
Carcinogenicity (trinary) Non-required 0.6698 66.98%
Eye corrosion - 0.9914 99.14%
Eye irritation - 0.8973 89.73%
Skin irritation - 0.8293 82.93%
Skin corrosion - 0.9556 95.56%
Ames mutagenesis - 0.5900 59.00%
Human Ether-a-go-go-Related Gene inhibition + 0.8057 80.57%
Micronuclear - 0.6026 60.26%
Hepatotoxicity - 0.8198 81.98%
skin sensitisation - 0.8626 86.26%
Respiratory toxicity + 0.5444 54.44%
Reproductive toxicity + 0.6333 63.33%
Mitochondrial toxicity + 0.6000 60.00%
Nephrotoxicity - 0.7017 70.17%
Acute Oral Toxicity (c) III 0.6006 60.06%
Estrogen receptor binding + 0.7571 75.71%
Androgen receptor binding + 0.7352 73.52%
Thyroid receptor binding + 0.6906 69.06%
Glucocorticoid receptor binding + 0.7867 78.67%
Aromatase binding + 0.5604 56.04%
PPAR gamma + 0.8207 82.07%
Honey bee toxicity - 0.6221 62.21%
Biodegradation - 0.8000 80.00%
Crustacea aquatic toxicity - 0.5500 55.00%
Fish aquatic toxicity + 0.9768 97.68%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL1293249 Q13887 Kruppel-like factor 5 99.17% 86.33%
CHEMBL1951 P21397 Monoamine oxidase A 98.88% 91.49%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 98.79% 91.11%
CHEMBL1075094 Q16236 Nuclear factor erythroid 2-related factor 2 95.97% 96.00%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 95.08% 96.09%
CHEMBL226 P30542 Adenosine A1 receptor 94.71% 95.93%
CHEMBL2581 P07339 Cathepsin D 93.92% 98.95%
CHEMBL3060 Q9Y345 Glycine transporter 2 92.67% 99.17%
CHEMBL221 P23219 Cyclooxygenase-1 92.22% 90.17%
CHEMBL1806 P11388 DNA topoisomerase II alpha 91.74% 89.00%
CHEMBL3401 O75469 Pregnane X receptor 89.54% 94.73%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 89.23% 95.56%
CHEMBL2716 Q8WUI4 Histone deacetylase 7 89.22% 89.44%
CHEMBL4208 P20618 Proteasome component C5 88.42% 90.00%
CHEMBL3475 P05121 Plasminogen activator inhibitor-1 88.38% 83.00%
CHEMBL3137262 O60341 LSD1/CoREST complex 86.20% 97.09%
CHEMBL2007 P16234 Platelet-derived growth factor receptor alpha 85.15% 91.07%
CHEMBL2035 P08912 Muscarinic acetylcholine receptor M5 85.05% 94.62%
CHEMBL2563 Q9UQL6 Histone deacetylase 5 84.35% 89.67%
CHEMBL3038477 P67870 Casein kinase II alpha/beta 84.06% 99.23%
CHEMBL3714130 P46095 G-protein coupled receptor 6 83.87% 97.36%
CHEMBL3476 O15111 Inhibitor of nuclear factor kappa B kinase alpha subunit 82.63% 95.83%
CHEMBL340 P08684 Cytochrome P450 3A4 82.38% 91.19%
CHEMBL4261 Q16665 Hypoxia-inducible factor 1 alpha 81.98% 85.14%
CHEMBL1907603 Q05586 Glutamate NMDA receptor; GRIN1/GRIN2B 81.94% 95.89%
CHEMBL4481 P35228 Nitric oxide synthase, inducible 80.92% 94.80%
CHEMBL3091268 Q92753 Nuclear receptor ROR-beta 80.11% 95.50%

Plants that contains it

Top
Below are displayed all the plants proven (via scientific papers) to contain this compound!
To see more specific details click the taxa you are interested in.
Polygala tenuifolia

Cross-Links

Top
PubChem 10011766
LOTUS LTS0042070
wikiData Q105005693